Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 7, 2016; 22(33): 7587-7594
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7587
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7587
Table 2 Prevalence of H. pylori resistance to clarithromycin and fluoroquinolones in each region
| Northern(n = 36) | North-Eastern (n = 138) | Central-Western(n = 26) | South-Eastern (n = 217) | Southern(n = 73) | P value | Total (n = 490) | |
| Clarithromycin resistance | 16.6% | 14.5% | 19.2% | 17.5% | 19.1% | 0.55 | 16.9% (95%CI: 13.7%-20.6%) |
| Fluoroquinolones resistance | 2.7% | 13.7% | 15.4% | 13.8% | 16.4% | 0.06 | 13.5% (95%CI: 10.6%-16.8%) |
- Citation: Sanches BS, Martins GM, Lima K, Cota B, Moretzsohn LD, Ribeiro LT, Breyer HP, Maguilnik I, Maia AB, Rezende-Filho J, Meira AC, Pinto H, Alves E, Mascarenhas R, Passos R, de Souza JD, Trindade OR, Coelho LG. Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey. World J Gastroenterol 2016; 22(33): 7587-7594
- URL: https://www.wjgnet.com/1007-9327/full/v22/i33/7587.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i33.7587